Immunoassays In R&D Market

Company Headquarters: Washington D.C., US Founded: 1969 Workforce: ~77,000 Company Working: Danaher Corporation (Danaher) designs, manufactures, and markets professional, medical, industrial, and commercial products & services all over the world. The company operates in three major business segments, namely, life sciences, diagnostics, and environmental and applied solutions. Its life sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. The company operates through more than 20 subsidiaries in the global market. Danaher’s life sciences segment operates through its seven subsidiaries, namely, Beckman Coulter Life Sciences, Integrated DNA Technologies (IDT), Leica Microsystems, Molecular Devices, Pall, Phenomenex, and SCIEX. The company’s diagnostics segment operates through five major subsidiaries, namely, Beckman Coulter, Cepheid, HemoCue, Leica Biosystems, and Radiometer. Danaher’s environmental and applied solutions segment operates through 12 major subsidiaries, namely, ChemTreat, Laetus GmbH, and Esko, among others.

Company Headquarters: Erlangen Germany Founded: 1957 Workforce: ~66,000 Company Working: Siemens Healthineers AG is the parent company for several medical technology companies and is. Siemens Healthineers is connected to the larger corporation, Siemens AG. The company offers intelligent diagnostic systems in the medical space. It has a strong network and presence in over 200 countries. Siemens operates through segments, namely, imaging, diagnostics, advanced therapies, and services. It operates through multiple production and manufacturing facilities, office buildings, warehouses, research and development facilities, and sales facilities in Beijing, Boston, London, Munich, Paris, Palo Alto, Stockholm, and Tel Aviv.

Company Headquarters: Cambridge, UK Founded: 1998 Workforce: ~1,750 Company Working: Abcam plc is a global life sciences company that discovers, develops, and distributes high-quality biological reagents and tools for research, drug discovery, and diagnostics. It works across the industry to help life scientists complete their projects more quickly. It collaborates with life science organizations to develop novel binders for drug discovery, in-vitro diagnostics, and therapeutics. It supplies over 110,000 products to two-thirds of the world's life scientists to research protein targets, including antibodies, proteins, lysates, biochemicals, kits, and assays. It has thirteen locations globally and operates in over 130 countries worldwide. It manufactures its products in specialized facilities and sources them from over four hundred partners worldwide.

Company Headquarters: Kobe, Japan Founded: 1968 Workforce: ~ 8,715 Company Working: Sysmex Corporation (Sysmex) develops, manufactures, sells, and exports/imports diagnostic instruments, reagents, and related software. The company provides products, services, and support to customers in more than 190 countries. Its key customers include national and other public hospitals, private hospitals, universities, research institutes, other medical institutions. Sysmex operates in the domain of healthcare testing, which involves examining blood, urine, and other samples. The company's business is in the domain of in vitro diagnostics (IVD), which is essential to the diagnosis and treatment of diseases. The company operates through various subsidiaries in different parts of the world, including the Americas, EMEA, and Asia-Pacific.

Company Headquarters: France Founded: 1963 Workforce: ~10,400 Company Working: BioMérieux is engaged in developing in-vitro diagnostics and microbiology testing services for the treatment of various infectious diseases. The company offers clinical diagnostics & industrial microbiology products and researches and develops solutions to treat diseases, such as sepsis, infections, cancer, cardiovascular diseases. It also develops solutions for biomarkers, biopharmaceutical control, and food safety. The firm operates through four major business segments, including microbiology, immunoassays, molecular biology, and industrial applications. The firm has a presence in more than 160 countries across the globe.

Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.